Biotech companies are profound for developing groundbreaking treatments and therapies for diverse medical conditions and life-threatening diseases. Buoyed by successful commercial sales that help yield quick returns, biotech companies are rebounding from their last year’s lows.
Below, I have evaluated two quality biotech stocks, Bionano Genomics, Inc. (BNGO) and Cidara Therapeutics, Inc. (CDTX), to determine the better choice. Before analyzing these stocks, let’s discuss what’s happening in the biotech sector.
